SCHEMBL6141

SCHEMBL6141

NCN1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20040342 0.96 HRH3 (0.45)
Hydrochloric Acid SCHEMBL11313740 0.96
SCHEMBL580308 0.96
SCHEMBL19286358 0.96
Hydrochloric Acid SCHEMBL8303248 0.96
Hydrochloric Acid SCHEMBL9334893 0.93
SCHEMBL3200905 0.92
SCHEMBL7353993 0.90
SCHEMBL10698992 0.87 LMNA (0.35)
Urea SCHEMBL7781133 0.85 L3MBTL1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 776 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4482529-A1 PEPTIDE LINKERS COMPRISING TWO OR MORE PAYLOADS Araris Biotech AG (CH) 2025-01-01 EP claimed
CN-118742328-A Peptide linker comprising two or more payloads 阿拉里斯生物技术股份公司 2024-10-01 CN claimed
WO-2023161291-A1 PEPTIDE LINKERS COMPRISING TWO OR MORE PAYLOADS ARARIS BIOTECH AG (CH) 2023-08-31 WO claimed
CN-112654620-B Novel pyrazolopyridine compounds for the treatment of autoimmune diseases 豪夫迈·罗氏有限公司 2023-08-04 CN claimed
EP-3847173-B1 NOVEL PYRAZOLOPYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE HOFFMANN LA ROCHE (CH) 2023-04-12 EP claimed
EP-3952995-A1 BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS Riboscience LLC (US) 2022-02-16 EP claimed
CN-114040915-A Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors 里伯赛恩斯有限责任公司 2022-02-11 CN claimed
US-20210355122-A1 PYRAZOLOPYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE HOFFMANN-LA ROCHE INC. (US) 2021-11-18 US claimed
US-20210323981-A1 FREE AMINO COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION HOFFMANN-LA ROCHE INC. (US) 2021-10-21 US claimed
EP-3883937-A1 FREE AMINO COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION F. Hoffmann-La Roche AG (CH) 2021-09-29 EP claimed
US-5162523-A CEPHALOSPORIN ANTIBACTERIAL COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 1992-11-10 US claimed
US-5159077-A Bactericide, antibiotic HOFFMANN-LA ROCHE INC. (US) 1992-10-27 US claimed
WO-1992000981-A1 NOVEL 3-SUBSTITUTED CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF DAE WOONG PHARMACEUTICAL CO., LTD. (KR) 1992-01-23 WO claimed
EP-0409081-A1 Beta-Lactam Derivatives F. HOFFMANN-LA ROCHE AG (CH) 1991-01-23 EP claimed
US-4946837-A ANTIBIOTICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-08-07 US claimed
EP-0314483-A1 Preparation of benzamides ERBAMONT, INC. (US) 1989-05-03 EP claimed
CN-1003236-B Preparation method of 6, 7-disubstituted-1-cyclopropyl-1, 4-dihydro-4-oxo-1, 8-naphthyridine-3-carboxylic acid 拜尔公司 1989-02-08 CN claimed
US-4717459-A Electrolytic gold plating solution SHINKO ELECTRIC INDUSTRIES CO., LTD. (JP) 1988-01-05 US claimed
EP-0047207-A1 N-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4-amino-5-methyl-sulfamoyl benzamide, process for its preparation and its use as a medicine SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) 1982-03-10 EP claimed
US-4235774-A ANIMAL GROWTH REGULATORS BAYER AKTIENGESELLSCHAFT (DE) 1980-11-25 US claimed